Algert Global’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.93M | Buy |
165,343
+7,623
| +5% | +$88.8K | 0.04% | 645 |
|
2025
Q1 | $1.17M | Sell |
157,720
-272,794
| -63% | -$2.03M | 0.03% | 739 |
|
2024
Q4 | $2.58M | Buy |
430,514
+354,191
| +464% | +$2.12M | 0.06% | 519 |
|
2024
Q3 | $391K | Buy |
76,323
+12,000
| +19% | +$61.5K | 0.01% | 946 |
|
2024
Q2 | $233K | Sell |
64,323
-103,163
| -62% | -$374K | 0.01% | 1223 |
|
2024
Q1 | $538K | Hold |
167,486
| – | – | 0.02% | 756 |
|
2023
Q4 | $821K | Sell |
167,486
-156,959
| -48% | -$769K | 0.03% | 672 |
|
2023
Q3 | $1.77M | Buy |
324,445
+28,200
| +10% | +$154K | 0.08% | 405 |
|
2023
Q2 | $1.99M | Sell |
296,245
-72,750
| -20% | -$488K | 0.09% | 386 |
|
2023
Q1 | $3.26M | Buy |
368,995
+76,638
| +26% | +$677K | 0.15% | 193 |
|
2022
Q4 | $2.23M | Buy |
292,357
+58,609
| +25% | +$448K | 0.12% | 262 |
|
2022
Q3 | $1.66M | Sell |
233,748
-57,787
| -20% | -$411K | 0.1% | 338 |
|
2022
Q2 | $2.36M | Buy |
291,535
+181,559
| +165% | +$1.47M | 0.18% | 137 |
|
2022
Q1 | $1.53M | Buy |
+109,976
| New | +$1.53M | 0.1% | 335 |
|